A team of physicians and scientists at UAB discovered that a kinase protein, mixed lineage kinase 4, also known as MLK4, plays a crucial role in survival of patient-derived brain cancer stem cells in pre-clinical animal models. The findings suggest that MLK4 could potentially be a useful target for cancer treatment.
With funding providing by the Laura Crandall Brown Foundation and the Ovarian Cancer Institute, researchers at Georgia Tech have developed a method to detect ovarian cancer that is highly accurate in patients with Stage 1 disease.
"The challenge of this is not only building the center, but attracting users across the national community and for them to become aware of what we have to offer," says Marcas Bamman, PhD, director of the new REACT Center and MR3 Network Coordinating Center at UAB.
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: